Projects per year
Organization profile
Center of Infectious Disease and Signaling Research (CIDSR)
The rapid spread of emerging infectious agents has summoned urgently with capacity building to counteract the invasion. To achieve effective prevention and mitigate the threat of citizens in Taiwan, Center of Infectious Disease and Signaling Research (CIDSR) is established by integrating the outstanding NCKU research groups into one roof center. The CIDSR has actively engaged with International Institutes to form a scholar platform offering to cultivate and identify talented individual interesting in the subject. The mission of CIDSR is to institute innovative research within a specific topic and to improve quality of patient cares.
Fingerprint
Dive into the research topics where Center of Infectious Disease and Signaling Research is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
剖析干擾素相關基因特徵在口腔腫瘤微環境之角色: 治療策略與生物標記開發-探討粒線體DNA損傷所誘導干擾素路徑在口腔癌發炎腫瘤微環境之角色:診斷標記與機制研究(2/3)
Chang, J.
19-08-01 → 20-07-31
Project: Research project
-
-
Phase I Dose-Escalation Study of SCB01A, a Microtubule Inhibitor with Vascular Disrupting Activity, in Patients with Advanced Solid Tumors
Shiah, H. S., Chiang, N. J., Lin, C. C., Yen, C. J., Tsai, H. J., Wu, S. Y., Su, W. C., Chang, K. Y., Wang, C. C., Chang, J. Y. & Chen, L. T., 2021 Apr, In: Oncologist. 26, 4, p. e567-e579Research output: Contribution to journal › Article › peer-review
Open Access -
A Simplified Diagnostic Classification Scheme of Chemotherapy-Induced Peripheral Neuropathy
Huang, H. W., Wu, P. Y., Su, P. F., Li, C. I., Yeh, Y. M., Lin, P. C., Hsu, K. F., Shen, M. R., Chang, J. Y. & Lin, C. C. K., 2020, In: Disease Markers. 2020, 3402108.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Author Correction: Germline susceptibility variants impact clinical outcome and therapeutic strategies for stage III colorectal cancer (Scientific Reports, (2019), 9, 1, (3931), 10.1038/s41598-019-40571-0)
Lin, P. C., Yeh, Y. M., Wu, P. Y., Hsu, K. F., Chang, J. Y. & Shen, M. R., 2020 Dec 1, In: Scientific reports. 10, 1, 12216.Research output: Contribution to journal › Comment/debate › peer-review
Open Access